Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2024-12-20

Clinical Trial Update: HBOC-201 Expanded Access Protocol for Life-threatening Anemia for Whom Allogeneic Blood Transfusion is Not an Option

View source ↗

Summary

The HBOC-201 expanded access protocol for life-threatening anemia in patients without viable allogeneic transfusion options is no longer available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HBOC-201

Snippet

Sponsor: Mauricio Lynn | Conditions: Anemia | Status: NO_LONGER_AVAILABLE